Determinants of eye drop size.
暂无分享,去创建一个
[1] W. P. Munroe,et al. Systemic Side Effects Associated with the Ophthalmic Administration of Timolol , 1985, Drug intelligence & clinical pharmacy.
[2] J. Sorab,et al. Tactile sensory monitoring of clinician-applied forces during delivery of newborns , 1988, IEEE Transactions on Biomedical Engineering.
[3] C. M. Lederer,et al. Drop size of commercial glaucoma medications. , 1986, American journal of ophthalmology.
[4] R. Brown,et al. Reduction of phenylephrine drop size in infants achieves equal dilation with decreased systemic absorption. , 1987, Archives of ophthalmology.
[5] R G Fiscella,et al. Costs of glaucoma medications. , 1998, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[6] R. Huupponen,et al. Systemic absorption of ocular scopolamine in patients. , 1990, Journal of ocular pharmacology.
[7] P. Rivers. Compliance Aids — Do They Work? , 1992, Drugs & aging.
[8] A. Flach. Systemic toxicity. Associated with topical ophthalmic medications. , 1994, The Journal of the Florida Medical Association.
[9] J. Cooper,et al. Cooper and Gunn's Dispensing for Pharmaceutical Students , 1966 .
[10] J. Robinson,et al. Quantitative precorneal disposition of topically applied pilocarpine nitrate in rabbit eyes. , 1976, Journal of pharmaceutical sciences.
[11] J. Lang. Ocular drug delivery conventional ocular formulations , 1995 .
[12] A. Ludwig,et al. Physicochemical properties, NMR spectroscopy and tolerance of inclusion complexes of antazoline and tetracaine with hydroxypropyl-β-cyclodextrin , 1998 .
[13] A. Ludwig,et al. Influence of the physico-chemical properties of ophthalmic viscolysers on the weight of drops dispensed from a flexible dropper bottle. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[14] E. Gramer,et al. Verbesserung der Augentropfenapplikation und Compliance bei Glaukompatienten - Eine klinische Studie , 1997 .
[15] V. H. Lee. Precorneal, corneal, and postcorneal factors , 1993 .
[16] A. Ludwig,et al. Influence of the dropper tip design on the size of eye-drops , 2001 .
[17] Tomi Järvinen,et al. Ocular absorption following topical delivery , 1995 .
[18] H. Quigley. Number of people with glaucoma worldwide. , 1996, The British journal of ophthalmology.
[19] A. Winfield,et al. A study of the causes of non-compliance by patients prescribed eyedrops. , 1990, The British journal of ophthalmology.
[20] M. Kass,et al. Can ophthalmologists correctly identify patients defaulting from pilocarpine therapy? , 1986, American journal of ophthalmology.
[21] G. Mulley,et al. Practical problems with eye-drops among elderly ophthalmology outpatients. , 1992, Age and ageing.
[22] A. Robin,et al. Reformulation and drop size of apraclonidine hydrochloride. , 1992, American journal of ophthalmology.
[23] P Diggory,et al. Medical treatment of glaucoma--a reappraisal of the risks. , 1996, The British journal of ophthalmology.
[24] V. Leirer,et al. Adherence and Medication Instructions Review and Recommendations , 1988, Journal of the American Geriatrics Society.
[25] T. F. Patton,et al. Topically applied pilocarpine. Human pupillary response as a function of drop size. , 1980, Archives of ophthalmology.
[26] A. Urtti,et al. Minimizing systemic absorption of topically administered ophthalmic drugs. , 1993, Survey of ophthalmology.
[27] R G Radwin,et al. A conductive polymer sensor for measuring external finger forces. , 1991, Journal of biomechanics.
[28] F. Fraunfelder,et al. Systemic side effects from ophthalmic timolol and their prevention. , 1987, Journal of ocular pharmacology.
[29] John G. Webster,et al. Tactile Sensors for Robotics and Medicine , 1988 .
[30] V. H. Lee,et al. Topical ocular drug delivery: recent developments and future challenges. , 1986, Journal of ocular pharmacology.
[31] A. Ludwig,et al. Influence of the surface tension of eye drops on the retention of a tracer in the precorneal area of human eyes. , 1988, Journal de pharmacie de Belgique.
[32] Victor C. Strasburger,et al. Review and Recommendations , 1983 .
[33] M. Kelly,et al. A method of drop administration. , 1997, Ophthalmic surgery and lasers.
[34] N. Carliner,et al. Respiratory arrest following first dose of timolol ophthalmic solution. , 1983, Chest.
[35] N. Marquardt. Validation of Form-Fill-Seal , 1995 .
[36] C. Jho,et al. The effect of viscosity on the drop weight technique for the measurement of dynamic surface tension , 1984 .
[37] J W Shell,et al. Pharmacokinetics of topically applied ophthalmic drugs. , 1982, Survey of ophthalmology.
[38] J. André,et al. Comparison between estimates of hand volume and hand strengths with sex and age with and without anthropometric data in healthy working people , 1997, European Journal of Epidemiology.
[39] S. Klyce,et al. Determination of tear volume and tear flow. , 1966, Investigative ophthalmology.
[40] O. Olejnik. Conventional systems in ophthalmic drug delivery , 1993 .
[41] D. Holdsworth,et al. FATE OF CHLORBUTOL DURING STORAGE IN POLYETHYLENE DROPPER CONTAINERS AND SIMULATED PATIENT USE , 1984, Journal of clinical and hospital pharmacy.
[42] A. Canada,et al. Relationship of viscosity, contact time and prolongation of action of methylcellulose-containing ophthalmic solutions. , 1965, American journal of hospital pharmacy.
[43] J. Nelson. Corneal abrasion resulting from a unit dose artificial tear dispenser. , 1987, American journal of ophthalmology.
[44] Stuart F. Ball,et al. Cost of β-Adrenergic Receptor Blocking Agents for Ocular Hypertension , 1992 .
[45] J. Diamond,et al. Systemic Adverse Effects of Topical Ophthalmic Agents , 1997, Drugs & aging.
[46] J. P. Frangie. Clinical Pharmacokinetics of Various Topical Ophthalmic Delivery Systems , 1995, Clinical pharmacokinetics.
[47] L. Salminen. Review: systemic absorption of topically applied ocular drugs in humans. , 1990, Journal of ocular pharmacology.
[48] G. Merli,et al. Systemic effects of eye drops. , 1982, Archives of internal medicine.
[49] R. Brown,et al. The effect of reduced eyedrop size and eyelid closure on the therapeutic index of phenylephrine. , 1993, American journal of ophthalmology.
[50] J. Olesen,et al. Muscle palpation with controlled finger pressure: new equipment for the study of tender myofascial tissues , 1994, Pain.
[51] A. Rosenthal,et al. Educating the glaucoma patient. , 1983, The British journal of ophthalmology.
[52] J. Stevens,et al. Survey of the contamination of eyedrops of hospital inpatients and recommendations for the changing of current practice in eyedrop dispensing. , 1992, The British journal of ophthalmology.
[53] E. Palmer. How safe are ocular drugs in pediatrics? , 1986, Ophthalmology.
[54] T. Zimmerman,et al. Facilitating patient compliance in glaucoma therapy. , 1983, Survey of ophthalmology.
[55] C. Jho,et al. Drop weight technique for the measurement of dynamic surface tension , 1983 .
[56] M. Kelly,et al. Improving drop administration by patients. , 1996, Journal of ophthalmic nursing & technology.
[57] R. Glynn,et al. Falls in elderly patients with glaucoma. , 1991, Archives of ophthalmology.
[58] R. Brown,et al. Creating smaller eyedrops by reducing eyedropper tip dimensions. , 1985, American journal of ophthalmology.
[59] F. Hugues,et al. Systemic and Local Tolerability of Ophthalmic Drug Formulations , 1993, Drug safety.
[60] M. Kass,et al. A miniature compliance monitor for eyedrop medication. , 1984, Archives of ophthalmology.
[61] E O'Donoghue,et al. Beta blockers and the elderly with glaucoma: are we adding insult to injury? , 1995, The British journal of ophthalmology.
[62] A. Loewenstein,et al. Application of eye drops to the medial canthus , 1994, Graefe's Archive for Clinical and Experimental Ophthalmology.
[63] S. Yalkowsky,et al. Review on the systemic delivery of insulin via the ocular route. , 2002, International journal of pharmaceutics.
[64] W. C. Stewart,et al. Daily Cost of β-Adrenergic Blocker Therapy , 1997 .
[65] Annick Ludwig,et al. Dispensing eye drops from flexible plastic dropper bottles. Part I : Influence of the packaging characteristics , 1999 .
[66] J. Parkin,et al. The Effect of Disodium Edetate and Sodium Chloride on the Stability of Ethylmercury Arising from the Decomposition of Thimerosal (Thiomersal) , 1995 .
[67] R. Brown,et al. Design of eyedropper tips for topical beta-blocking agents. , 1986, American journal of ophthalmology.
[68] Letocha Ce. Methods for self-administration of eyedrops. , 1985 .
[69] W. Hook,et al. Assessment of thumb to index pulp to pulp pinch grip strengths. , 1986, Journal of hand surgery.
[70] J. Gaddum,et al. United States Pharmacopeia , 1955, Nature.
[71] E P O'Sullivan,et al. Prescription of eye drops , 2001, Postgraduate medical journal.
[72] T. F. Patton. Pharmacokinetic evidence for improved ophthalmic drug delivery by reduction of instilled volume. , 1977, Journal of pharmaceutical sciences.
[73] Camilo Escobar,et al. Drop Size and Systemic Adverse Effects in Timolol Ophthalmic Solution , 1990, DICP : the annals of pharmacotherapy.
[74] J. Robinson,et al. Drop size and initial dosing frequency problems of topically applied ophthalmic drugs. , 1974, Journal of pharmaceutical sciences.
[75] J. Webster,et al. A silicon-based tactile sensor for finger-mounted applications , 1998, IEEE Transactions on Biomedical Engineering.
[76] A. Ludwig,et al. The influence of penetration enhancers on the volume instilled of eye drops. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[77] A. Corlett. Caring for Older People: Aids to compliance with medication , 1996, BMJ.
[78] G. Petursson,et al. Treatment of glaucoma using minidrops of clonidine. , 1984, Archives of ophthalmology.
[79] John W. Shell. Ophthalmic drug delivery systems , 1984 .